Literature DB >> 8445721

trans-dominant interference with virus infection at two different stages by a mutant envelope protein of Friend murine leukemia virus.

T Matano1, T Odawara, M Ohshima, H Yoshikura, A Iwamoto.   

Abstract

A dominant negative mutant Friend murine leukemia virus (FMLV) env gene was cloned from an immunoselected Friend erythroleukemia cell. The mutant env had a point mutation which resulted in a Cys-to-Arg substitution at the 361st amino acid in the FMLV envelope protein (Env). The mutant Env was retained in the endoplasmic reticulum (ER) and accumulated because of its slow degradation. The NIH 3T3 cells expressing the mutant env were resistant to ecotropic Moloney MLV (MoMLV) penetration, suggesting that the mutant Env traps the ecotropic MLV receptors in the ER. When the mutant env gene was transfected into and expressed in the cells persistently infected with MoMLV, the wild-type Env was trapped in the ER, and the MoMLV production was suppressed. Thus, the mutant Env accumulating in the ER trans-dominantly and efficiently interfered with the ecotropic MLV infection at both the early and the late stages.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445721      PMCID: PMC240271     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

Authors:  J D Lifson; M B Feinberg; G R Reyes; L Rabin; B Banapour; S Chakrabarti; B Moss; F Wong-Staal; K S Steimer; E G Engleman
Journal:  Nature       Date:  1986 Oct 23-29       Impact factor: 49.962

2.  Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes.

Authors:  Y Misumi; Y Misumi; K Miki; A Takatsuki; G Tamura; Y Ikehara
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

3.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.

Authors:  J Sodroski; W C Goh; C Rosen; K Campbell; W A Haseltine
Journal:  Nature       Date:  1986 Jul 31-Aug 6       Impact factor: 49.962

4.  Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.

Authors:  R K Saiki; T L Bugawan; G T Horn; K B Mullis; H A Erlich
Journal:  Nature       Date:  1986 Nov 13-19       Impact factor: 49.962

5.  Nucleotide sequence of the envelope gene of Friend murine leukemia virus.

Authors:  W Koch; G Hunsmann; R Friedrich
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

6.  Mutant cells that abnormally process plasma membrane glycoproteins encoded by murine leukemia virus.

Authors:  T Fitting; M Ruta; D Kabat
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

7.  Friend erythroleukaemia cell mutants defective in viral gene expression.

Authors:  J Yokota; A Iwamoto; A Suzuki; S Yamaguchi-Tejima; Y Kitamura; H Yoshikura
Journal:  J Gen Virol       Date:  1984-02       Impact factor: 3.891

8.  Replication-competent Moloney murine leukemia virus carrying a bacterial suppressor tRNA gene: selective cloning of proviral and flanking host sequences.

Authors:  W Reik; H Weiher; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  Glycoprotein encoded by the Friend spleen focus-forming virus.

Authors:  S Dresler; M Ruta; M J Murray; D Kabat
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

10.  Mutations of the Rous sarcoma virus env gene that affect the transport and subcellular location of the glycoprotein products.

Authors:  J W Wills; R V Srinivas; E Hunter
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

View more
  7 in total

1.  Properties of the naturally occurring soluble surface glycoprotein of ecotropic murine leukemia virus: binding specificity and possible conformational change after binding to receptor.

Authors:  H Ikeda; K Kato; T Suzuki; H Kitani; Y Matsubara; S Takase-Yoden; R Watanabe; M Kitagawa; S Aizawa
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Inhibition of murine leukemia virus envelope protein (env) processing by intracellular expression of the env N-terminal heptad repeat region.

Authors:  Wu Ou; Jonathan Silver
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Interaction between the dominant negative mutant and the wild-type envelope proteins of Friend murine leukemia virus.

Authors:  T Matano; T Odawara; M Ohshima; A Iwamoto; H Yoshikura
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

4.  Structural elements in glycoprotein 70 from polytropic Friend mink cell focus-inducing virus and glycoprotein 71 from ecotropic Friend murine leukemia virus, as defined by disulfide-bonding pattern and limited proteolysis.

Authors:  M Linder; V Wenzel; D Linder; S Stirm
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus.

Authors:  Samuel L Murphy; Maeran Chung-Landers; Marek Honczarenko; Glen N Gaulton
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Threshold number of provirus copies required per cell for efficient virus production and interference in moloney murine leukemia virus-infected NIH 3T3 cells.

Authors:  T Odawara; M Oshima; K Doi; A Iwamoto; H Yoshikura
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Mutations within a putative cysteine loop of the transmembrane protein of an attenuated immunodeficiency-inducing feline leukemia virus variant inhibit envelope protein processing.

Authors:  C C Burns; M L Poss; E Thomas; J Overbaugh
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.